ATNM
Price
$1.30
Change
-$0.09 (-6.47%)
Updated
Apr 4, 02:26 PM (EDT)
Capitalization
47.42M
38 days until earnings call
IMNM
Price
$5.91
Change
-$0.33 (-5.29%)
Updated
Apr 4, 02:41 PM (EDT)
Capitalization
542.57M
34 days until earnings call
Ad is loading...

ATNM vs IMNM

Header iconATNM vs IMNM Comparison
Open Charts ATNM vs IMNMBanner chart's image
Actinium Pharmaceuticals
Price$1.30
Change-$0.09 (-6.47%)
Volume$1.2K
Capitalization47.42M
Immunome
Price$5.91
Change-$0.33 (-5.29%)
Volume$580
Capitalization542.57M
ATNM vs IMNM Comparison Chart
Loading...
ATNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATNM vs. IMNM commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATNM is a Hold and IMNM is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (ATNM: $1.39 vs. IMNM: $6.24)
Brand notoriety: ATNM and IMNM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATNM: 43% vs. IMNM: 93%
Market capitalization -- ATNM: $47.42M vs. IMNM: $542.57M
ATNM [@Biotechnology] is valued at $47.42M. IMNM’s [@Biotechnology] market capitalization is $542.57M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATNM’s FA Score shows that 0 FA rating(s) are green whileIMNM’s FA Score has 0 green FA rating(s).

  • ATNM’s FA Score: 0 green, 5 red.
  • IMNM’s FA Score: 0 green, 5 red.
According to our system of comparison, both ATNM and IMNM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATNM’s TA Score shows that 5 TA indicator(s) are bullish while IMNM’s TA Score has 4 bullish TA indicator(s).

  • ATNM’s TA Score: 5 bullish, 5 bearish.
  • IMNM’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ATNM and IMNM are a good buy in the short-term.

Price Growth

ATNM (@Biotechnology) experienced а -26.46% price change this week, while IMNM (@Biotechnology) price change was -14.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.29%. For the same industry, the average monthly price growth was -17.13%, and the average quarterly price growth was -18.92%.

Reported Earning Dates

ATNM is expected to report earnings on May 12, 2025.

IMNM is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-11.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($543M) has a higher market cap than ATNM($47.4M). ATNM YTD gains are higher at: 10.317 vs. IMNM (-41.243). ATNM has higher annual earnings (EBITDA): -44.15M vs. IMNM (-109.95M). IMNM has more cash in the bank: 240M vs. ATNM (78.7M). ATNM has less debt than IMNM: ATNM (1.71M) vs IMNM (2.72M). IMNM has higher revenues than ATNM: IMNM (10.1M) vs ATNM (81K).
ATNMIMNMATNM / IMNM
Capitalization47.4M543M9%
EBITDA-44.15M-109.95M40%
Gain YTD10.317-41.243-25%
P/E RatioN/AN/A-
Revenue81K10.1M1%
Total Cash78.7M240M33%
Total Debt1.71M2.72M63%
FUNDAMENTALS RATINGS
ATNM: Fundamental Ratings
ATNM
OUTLOOK RATING
1..100
29
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATNMIMNM
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 9 days ago
73%
Bullish Trend 9 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Ad is loading...
ATNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AP2.170.06
+2.84%
Ampco-Pittsburgh Corp
WDAY228.33-7.06
-3.00%
Workday
ADT8.08-0.30
-3.58%
ADT
JBGS15.54-0.94
-5.70%
JBG SMITH Properties
SNBR5.61-1.27
-18.46%
Sleep Number Corp

ATNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATNM has been loosely correlated with GBIO. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ATNM jumps, then GBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATNM
1D Price
Change %
ATNM100%
-8.55%
GBIO - ATNM
46%
Loosely correlated
+7.37%
LOGC - ATNM
43%
Loosely correlated
-3.50%
ABOS - ATNM
33%
Loosely correlated
-8.52%
PLRX - ATNM
33%
Loosely correlated
-7.09%
IMNM - ATNM
33%
Loosely correlated
-7.00%
More

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with KYMR. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-7.00%
KYMR - IMNM
52%
Loosely correlated
-10.13%
IDYA - IMNM
50%
Loosely correlated
-4.77%
BEAM - IMNM
50%
Loosely correlated
-10.93%
RXRX - IMNM
49%
Loosely correlated
-9.07%
ADVM - IMNM
49%
Loosely correlated
-7.51%
More